Stockreport

Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights [Yahoo! Finance]

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF EC and U.S. FDA label updates for CARVYKTI ® to include overall survival benefit versus standard of care Over 9,000 patients treated to date Initiated CARVYKTI ® co [Read more]